Felix Maldonado

FDA investigator

Appears on 6 documents from 2009 to 2019, mostly at sites in New York. Most often cites general requirements (21 CFR 211.160).

6
Documents on file
10.7
Observations per 483
2009
First seen
2019
Most recent

What they cite most

From 61 observations

Activity by year

2009: 1, 2011: 1, 2013: 1, 2015: 1, 2016: 1, 2019: 1

Where

New York 3 · India 2 · China 1

Is Felix Maldonado coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 SOFTGEL HEALTHCARE PRIVATE LIMITEDFeb 22, 2019 · Chengalpattu, India
483 Sun Pharmaceuticals Industries, IncNov 16, 2016 · S.A.S. Nagar, Mohali, India
483 Hi-Tech Pharmacal, an AKORN CompanyJul 20, 2015 · Amityville, New York
483 Qilu Pharmaceutical Co., Ltd.(High Tech Zone Site)Jul 18, 2013 · Jinan, China
483 APP PharmaceuticalsJul 8, 2011 · Grand Island, New York
483 Ohm Laboratories, Inc.Aug 12, 2009 · Gloversville, New York

About this profile

What does Felix Maldonado inspect?

Felix Maldonado appears on 6 documents on file covering 6 sites, mostly in New York.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.194 and 21 CFR 211.166.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Felix Maldonado is dated Feb 22, 2019.